Showing 14 of 74 recruiting trials for “sickle-cell-s-d-punjab-disease”
RecruitingNCT04416178 ↗
Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
👨⚕️ Liza M. Johnson, MD, MPH, MSB, St. Jude Children's Research Hospital📍 1 site📅 Started Dec 2020View details ↗
Enrolling by InvitationNCT04628585 ↗
Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
👨⚕️ Sherif M. Badawy, MD, MS, Ann & Robert H Lurie Children's Hospital of Chicago📍 1 site📅 Started Sep 2020View details ↗
High-flow Oxygen for Vaso-occlusive Pain Crisis
👨⚕️ Armand Mekontso, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Apr 2020View details ↗
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
👨⚕️ Robert Molokie, University of Illinois at Chicago College of Medicine📍 1 site📅 Started Jan 2020View details ↗
RecruitingNCT05376046 ↗
Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
👨⚕️ Robert Nickel, MD, Children's National Research Institute📍 7 sites📅 Started Apr 2018View details ↗
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
👨⚕️ Michael Frett, MD, St. Jude Children's Research Hospital📍 2 sites📅 Started Feb 2018View details ↗
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
👨⚕️ Damiano Rondelli, MD, University of Illinois at Chicago📍 1 site📅 Started Mar 2017View details ↗
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
👨⚕️ Shalini Shenoy, MD, Washington University School of Medicine📍 4 sites📅 Started Mar 2017View details ↗
RecruitingNCT03327428 ↗
Sickle-cell Disease Registry of the GPOH
👨⚕️ Joachim Kunz, Dr., Center for Child and Adolescent Medicine, University Medical Center Heidelberg📍 1 site📅 Started Dec 2016View details ↗
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
Enrolling by InvitationNCT00047996 ↗
Blood Collection for Research Related to Certain Diseases Involving Blood Vessels
👨⚕️ Swee Lay Thein, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 2 sites📅 Started Nov 2002View details ↗
← PreviousPage 4 of 4
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →